Epithelial plasticity in cancer: Unmasking a MicroRNA network for TGF- β -, Notch-, and Wnt-Mediated EMT

Journal of Oncology

Volumn 2015, Issue , 2015, Pages

  Zoni, Eugenio ^a   Van Der Pluijm, Gabri ^a   Gray, Peter C ^b   Kruithof De Julio, Marianna ^a,c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^c Centre for Biomedical Genetics   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CTBP1 PROTEIN; CTBP2 PROTEIN; DISHEVELLED 2; DVL3 PROTEIN; E1A ASSOCIATED P300 PROTEIN; MICRORNA; MICRORNA 1; MICRORNA 132; MICRORNA 145; MICRORNA 16; MICRORNA 200; MICRORNA 200B; MICRORNA 200C; MICRORNA 24; MICRORNA 31; MICRORNA 375; MICRORNA 9; MYC PROTEIN; NOTCH RECEPTOR; PPP2R1A PROTEIN; PPP2R1B PROTEIN; PROTEIN; PSEN1 PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; ROCK2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT PROTEIN;

CELL FUNCTION; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIAL PLASTICITY; EPITHELIUM CELL; GENE TARGETING; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PROTEIN PROTEIN INTERACTION; REVIEW; WNT SIGNALING PATHWAY;

EID: 84926666068     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2015/198967     Document Type: Review

References (89)

1. J. P. Thiery and J. P. Sleeman, "Complex networks orchestrate epithelial-mesenchymal transitions", Nature Reviews Molecular Cell Biology, vol. 7, no. 2, pp. 131-142, 2006.
2. R. Kalluri, "EMT: when epithelial cells decide to become mesenchymal-like cells", Journal of Clinical Investigation, vol. 119, no. 6, pp. 1417-1419, 2009.
3. J. Fuxe, T. Vincent, and A. G. De Herreros, "Transcriptional crosstalk between TGFβ and stem cell pathways in tumor cell invasion: role of EMT promoting Smad complexes", Cell Cycle, vol. 9, no. 12, pp. 2363-2374, 2010.
4. L. A. Timmerman, J. Grego-Bessa, A. Raya et al., "Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation", Genes and Development, vol. 18, no. 1, pp. 99-115, 2004.
5. J. Zavadil and E. P. Böttinger, "TGF-β and epithelial-tomesenchymal transitions", Oncogene, vol. 24, no. 37, pp. 5764-5774, 2005.
6. J. Zavadil, L. Cermak, N. Soto-Nieves, and E. P. Böttinger, "Integration of TGF-β/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition", The EMBO Journal, vol. 23, no. 5, pp. 1155-1165, 2004.
7. T. Vergoulis, I. S. Vlachos, P. Alexiou et al., "Tar Base 6.0: capturing the exponential growth of miRNAtargetswith experimental support", Nucleic Acids Research, vol. 40, no. 1, pp. D222-D229, 2012.
8. M. Kanehisa and S. Goto, "KEGG: kyoto encyclopedia of genes and genomes", Nucleic Acids Research, vol. 28, no. 1, pp. 27-30, 2000.
9. I. S. Vlachos, N. Kostoulas, T. Vergoulis et al., "DIANAmiRPath v. 2.0: investigating the combinatorial effect of microRNAs in pathways", Nucleic Acids Research, vol. 40, no. 1, pp. W498-W504, 2012.
10. N. A. Bhowmick, M. Ghiassi, A. Bakin et al., "Transforming growth factor-β1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism", Molecular Biology of the Cell, vol. 12, no. 1, pp. 27-36, 2001.
11. C. Margadant and A. Sonnenberg, "Integrin-TGF-β crosstalk in fibrosis, cancer and wound healing", EMBO Reports, vol. 11, no. 2, pp. 97-105, 2010.
12. K. Abdelmohsen, E. R. Hutchison, E. K. Lee et al., "miR-375 inhibits differentiation of neurites by lowering HuD levels", Molecular and Cellular Biology, vol. 30, no. 17, pp. 4197-4210, 2010.
13. D. Baek, J. Villén, C. Shin, F. D. Camargo, S. P. Gygi, and D. P. Bartel, "The impact of microRNAs on protein output", Nature, vol. 455, no. 7209, pp. 64-71, 2008.
14. T. D. Schmittgen, "miR-31: a master regulator of metastasis?" Future Oncology, vol. 6, no. 1, pp. 17-20, 2010.
15. S. Valastyan, F. Reinhardt, N. Benaich et al., "A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis", Cell, vol. 137, no. 6, pp. 1032-1046, 2009.
16. S.-C. Wang, X.-L. Lin, J. Li et al., "MicroRNA-122 triggers mesenchymal-epithelial transition and suppresses hepatocellular carcinoma cell motility and invasion by targeting RhoA", PLoS ONE, vol. 9, no. 7, Article ID e101330, 2014.
17. R. Bijkerk, R. G. De Bruin, C. Van Solingen et al., "MicroRNA-155 functions as a negative regulator of RhoA signaling in TGF-beta-induced endothelial to mesenchymal transition", MicroRNA, vol. 1, no. 1, pp. 2-10, 2012.
18. Y. Lee, H. J. Kim, C. K. Park et al., "MicroRNA-124 regulates osteoclast differentiation", Bone, vol. 56, no. 2, pp. 383-389, 2013.
19. F. E. Lock, K. R. Ryan, N. S. Poulter, M. Parsons, and N. A. Hotchin, "Differential regulation of adhesion complex turnover by ROCK1 and ROCK2", PLoS ONE, vol. 7, no. 2, Article ID e31423, 2012.
20. J. Lynch, J. Fay, M. Meehan et al., "MiRNA-335 suppresses neuroblastoma cell invasiveness by direct targeting of multiple genes from the non-canonical TGF-β signalling pathway", Carcinogenesis, vol. 33, no. 5, pp. 976-985, 2012.
21. 2", Gut, vol. 61, no. 2, pp. 278-289, 2012.
22. F. Louafi, R. T. Martinez-Nunez, and T. Sanchez-Elsner, "MicroRNA-155 targets SMAD2 and modulates the response of macrophages to transforming growth factor-β", Journal of Biological Chemistry, vol. 285, no. 53, pp. 41328-41336, 2010.
23. M. Selbach, B. Schwanhäusser, N. Thierfelder, Z. Fang, R. Khanin, and N. Rajewsky, "Widespread changes in protein synthesis induced by microRNAs", Nature, vol. 455, no. 7209, pp. 58-63, 2008.
24. S. K. Gudey, R. Sundar, Y. Mu et al., "TRAF6 stimulates the tumor-promoting effects of TGFβ type I receptor through polyubiquitination and activation of presenilin", Science Signaling, vol. 7, no. 307, 2014.
25. K. A. Brown, M. E. Aakre, A. E. Gorska et al., "Induction by transforming growth factor-beta1 of epithelial to mesenchymal transition is a rare event in vitro", Breast Cancer Research, vol. 6, no. 3, pp. R215-R231, 2004.
26. A. Eger, A. Stockinger, J. Park et al., "β-Catenin and TGFβ signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition", Oncogene, vol. 23, no. 15, pp. 2672-2680, 2004.
27. W. J. Nelson and R. Nusse, "Convergence of wnt, β-catenin, and cadherin pathways", Science, vol. 303, no. 5663, pp. 1483-1487, 2004.
28. S. Masuda, K. Kumano, K. Shimizu et al., "Notch 1 oncoprotein antagonizes TGF-β/Smad-mediated cell growth suppression via sequestration of coactivator p300", Cancer Science, vol. 96, no. 5, pp. 274-282, 2005.
29. A. H. Schönthal, "Role of PP2A in intracellular signal transduction pathways", Frontiers in Bioscience, vol. 3, pp. D1262-D1273, 1998.
30. P. J. A. Eichhorn, M. P. Creyghton, and R. Bernards, "Protein phosphatase 2A regulatory subunits and cancer", Biochimica et Biophysica Acta: Reviews on Cancer, vol. 1795, no. 1, pp. 1-15, 2009.
31. J. Kroon, L. S. In't Veld, J. T. Buijs, H. Cheung, G. Van Der Horst, and G. Van Der Pluijm, "Glycogen synthase kinase-3β inhibition depletes the population of prostate cancer stem/progenitor-like cells and attenuates metastatic growth", Oncotarget, vol. 5, no. 19, pp. 8986-8994, 2014.
32. A. Bhardwaj, S. Singh, S. K. Srivastava et al., "Restoration of PPP2CA expression reverses epithelial-to-mesenchymal transition and suppresses prostate tumour growth and metastasis in an orthotopic mouse model", British Journal of Cancer, vol. 110, no. 8, pp. 2000-2010, 2014.
33. K. P. Porkka, E.-L. Ogg, O. R. Saramäki et al., "The miR-15amiR-16-1 locus is homozygously deleted in a subset of prostate cancers", Genes, Chromosomes and Cancer, vol. 50, no. 7, pp. 499-509, 2011.
34. M. Musumeci, V. Coppola, A. Addario et al., "Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer", Oncogene, vol. 30, no. 41, pp. 4231-4242, 2011.
35. M. Y. Wu and C. S. Hill, "TGF-β superfamily signaling in embryonic development and homeostasis", Developmental Cell, vol. 16, no. 3, pp. 329-343, 2009.
36. F. Chen, S. K. Hou, H. J. Fan, and Y. F. Liu, "MiR-15a-16 represses Cripto and inhibits NSCLC cell progression", Molecular and Cellular Biochemistry, vol. 391, no. 1-2, pp. 11-19, 2014.
37. P. C. Gray and W. Vale, "Cripto/GRP78modulation of the TGF- β pathway in development and oncogenesis", FEBS Letters, vol. 586, no. 14, pp. 1836-1845, 2012.
38. M. C. Rangel, H. Karasawa, N. P. Castro, T. Nagaoka, D. S. Salomon, and C. Bianco, "Role of Cripto-1 during epithelialtomesenchymal transition in development and cancer", The American Journal of Pathology, vol. 180, no. 6, pp. 2188-2200, 2012.
39. M. G. Lawrence, N. V. Margaryan, D. Loessner et al., "Reactivation of embryonic nodal signaling is associated with tumor progression and promotes the growth of prostate cancer cells", Prostate, vol. 71, no. 11, pp. 1198-1209, 2011.
40. P. C. Gray, G. Shani, K. Aung, J. Kelber, and W. Vale, "Cripto binds transforming growth factor β (TGF-β) and inhibits TGF- β signaling", Molecular and Cellular Biology, vol. 26, no. 24, pp. 9268-9278, 2006.
41. S. Kang, Y. Zhao, K. Hu et al., "MiR-124 exhibits antiproliferative and antiaggressive effects on prostate cancer cells through PACE4 pathway", Prostate, vol. 74, pp. 1095-1106, 2014.
42. L. P. Lim, N. C. Lau, P. Garrett-Engele et al., "Microarray analysis shows that some micro RNAs downregulate large numbers oftarget mRNAs", Nature, vol. 433, no. 7027, pp. 769-773, 2005.
43. Y. Geng, Y. Ju, F. Ren et al., "Insulin receptor substrate 1/2 (IRS1/2) regulates Wnt/β-Catenin signaling through blocking autophagic degradation of dishevelled", Journal of Biological Chemistry, vol. 289, no. 16, pp. 11230-11241, 2014.
44. 3a signalling are involved in E-cadherin expression and transforming growth factor-β1-induced repression in kidney epithelial cells", The FEBS Journal, vol. 278, no. 18, pp. 3370-3380, 2011.
45. A. V. Sorokin and J. Chen, "MEMO1, a new IRS1-interacting protein, induces epithelial-mesenchymal transition in mammary epithelial cells", Oncogene, vol. 32, no. 26, pp. 3130-3138, 2013.
46. M. Heni, J. Hennenlotter, M. Scharpf et al., "Insulin receptor isoforms A and B as well as insulin receptor substrates-1 and -2 are differentially expressed in prostate cancer", PLoS ONE, vol. 7, no. 12, Article ID e50953, 2012.
47. S. L. Neuhausen, M. L. Slattery, C. P. Garner, Y. C. Ding, M. Hoffman, and A. R. Brothman, "Prostate cancer risk and IRS1, IRS2, IGF1, and INS polymorphisms: strong association of IRS1 G972R variant and cancer risk", Prostate, vol. 64, no. 2, pp. 168-174, 2005.
48. C. Ragan, N. Cloonan, S. M. Grimmond, M. Zuker, and M. A. Ragan, "Transcriptome-wide prediction of miRNA targets in human and mouse using FASTH", PLoS ONE, vol. 4, no. 5, Article ID e5745, 2009.
49. Y. Chen, S. X. Wang, R. Mu et al., "Dysregulation of the MiR-324-5p-CUEDC2 axis leads to macrophage dysfunction and is associated with colon cancer", Cell Reports, pp. 1982-1993, 2014.
50. K. Yagi, M. Furuhashi, H. Aoki et al., "c-myc is a downstream target of the Smad pathway", Journal of Biological Chemistry, vol. 277, no. 1, pp. 854-861, 2002.
51. T.-C. He, A. B. Sparks, C. Rago et al., "Identification of c-MYC as a target of the APC pathway", Science, vol. 281, no. 5382, pp. 1509-1512, 1998.
52. V. H. Cowling and M. D. Cole, "E-cadherin repression contributes to c-Myc-induced epithelial cell transformation", Oncogene, vol. 26, no. 24, pp. 3582-3586, 2007.
53. S. F. Tavazoie, C. Alarcón, T. Oskarsson et al., "Endogenous human micro RNAs that suppress breast cancer metastasis", Nature, vol. 451, no. 7175, pp. 147-152, 2008.
54. V. B. Sampson, N. H. Rong, J. Han et al., "MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells", Cancer Research, vol. 67, no. 20, pp. 9762-9770, 2007.
55. X. Qu, L. Shen, Y. Zheng et al., "A signal transduction pathway from TGF-β1 to SKP2 via Akt1 and c-Myc and its correlation with progression in human melanoma", Journal of Investigative Dermatology, vol. 134, no. 1, pp. 159-167, 2014.
56. M. Sachdeva, S. Zhu, F. Wu et al., "p53 represses c-Myc through induction of the tumor suppressor miR-145", Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 9, pp. 3207-3212, 2009.
57. G. T. Bommer, I. Gerin, Y. Feng et al., "p53-mediated activation of miRNA34 candidate tumor-suppressor genes", Current Biology, vol. 17, no. 15, pp. 1298-1307, 2007.
58. N. R. Christoffersen, R. Shalgi, L. B. Frankel et al., "P53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC", Cell Death and Differentiation, vol. 17, no. 2, pp. 236-245, 2010.
59. A. Lal, F. Navarro, C. A. Maher et al., "miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "Seedless" 3βUTR microRNA recognition elements", Molecular Cell, vol. 35, no. 5, pp. 610-625, 2009.
60. E. Papadimitriou, E. Vasilaki, C. Vorvis et al., "Differential regulation of the two RhoA-specific GEF isoforms Net1/Net1A by TGF-β and miR-24: role in epithelial-to-mesenchymal transition", Oncogene, vol. 31, no. 23, pp. 2862-2875, 2012.
61. S. K. Singh, M. N. Kagalwala, J. Parker-Thornburg, H. Adams, and S. Majumder, "REST maintains self-renewal and pluripotency of embryonic stem cells", Nature, vol. 453, no. 7192, pp. 223-227, 2008.
62. K. A. O'Donnell, E. A. Wentzel, K. I. Zeller, C. V. Dang, and J. T. Mendell, "c-Myc-regulated microRNAs modulate E2F1 expression", Nature, vol. 435, no. 7043, pp. 839-843, 2005.
63. M. Dews, J. L. Fox, S. Hultine et al., "The Myc-miR-17 ∼ 92 axis blunts TGFβ signaling and production of multiple TGFβ- dependent antiangiogenic factors", Cancer Research, vol. 70, no. 20, pp. 8233-8246, 2010.
64. Y. Sun, F. T. Kolligs, M. O. Hottiger, R. Mosavin, E. R. Fearon, and G. J. Nabel, "Regulation of β-catenin transformation by the p300 transcriptional coactivator", Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 23, pp. 12613-12618, 2000.
65. R. Janknecht, N. J. Wells, and T. Hunter, "TGF-β-stimulated cooperation of Smad proteins with the coactivators CBP/p300", Genes and Development, vol. 12, no. 14, pp. 2114-2119, 1998.
66. S. E. Pursglove and J. P. Mackay, "CSL: a notch above the rest", International Journal of Biochemistry and Cell Biology, vol. 37, no. 12, pp. 2472-2477, 2005.
67. N. Vo and R. H. Goodman, "CREB-binding protein and p300 in transcriptional regulation", Journal of Biological Chemistry, vol. 276, no. 17, pp. 13505-13508, 2001.
68. J. C. Chrivia, R. P. S. Kwok, N. Lamb, M. Hagiwara, M. R. Montminy, and R. H. Goodman, "Phosphorylated CREB binds specifically to the nuclear protein CBP", Nature, vol. 365, no. 6449, pp. 855-859, 1993.
69. R. W. Stein, M. Corrigan, P. Yaciuk, J. Whelan, and E. Moran, "Analysis of E1A-mediated growth regulation functions: binding of the 300-kilodalton cellular product correlates with E1A enhancer repression function and DNA synthesis-inducing activity", Journal of Virology, vol. 64, no. 9, pp. 4421-4427, 1990.
70. R. Eckner, M. E. Ewen, D. Newsome et al., "Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor", Genes and Development, vol. 8, no. 8, pp. 869-884, 1994.
71. D. C. Bedford, L. H. Kasper, T. Fukuyama, and P. K. Brindle, "Target gene context influences the transcriptional requirement for the KAT3 family of CBP and p300 histone acetyltransferases", Epigenetics, vol. 5, no. 1, pp. 9-15, 2010.
72. K. Ishihama, M. Yamakawa, S. Semba et al., "Expression of HDAC1 and CBP/p300 in human colorectal carcinomas", Journal of Clinical Pathology, vol. 60, no. 11, pp. 1205-1210, 2007.
73. H. V. Heemers, J. D. Debes, and D. J. Tindall, "The role of the transcriptional coactivator p300 in prostate cancer progression", Advances in Experimental Medicine and Biology, vol. 617, pp. 535-540, 2008.
74. C. Péna, J. M. García, V. García et al., "The expression levels of the transcriptional regulators p300 and CtBP modulate the correlations between SNAIL, ZEB1, E-cadherin and vitamin D receptor in human colon carcinomas", International Journal of Cancer, vol. 119, no. 9, pp. 2098-2104, 2006.
75. C. Yokomizo, K. Yamaguchi, Y. Itoh et al., "High expression of p300 in HCC predicts shortened overall survival in association with enhanced epithelial mesenchymal transition of HCC cells", Cancer Letters, vol. 310, no. 2, pp. 140-147, 2011.
76. A. K. Ghosh and J. Varga, "The transcriptional coactivator and acetyltransferase p300 in fibroblast biology and fibrosis", Journal of Cellular Physiology, vol. 213, no. 3, pp. 663-671, 2007.
77. A. Kaimori, J. J. Potter, M. Choti, Z. Ding, E. Mezey, and A. A. Koteish, "Histone deacetylase inhibition suppresses the transforming growth factor β1-induced epithelial-to-mesenchymal transition in hepatocytes", Hepatology, vol. 52, no. 3, pp. 1033-1045, 2010.
78. A. Grimson, K. K.-H. Farh, W. K. Johnston, P. Garrett-Engele, L. P. Lim, and D. P. Bartel, "MicroRNA targeting specificity in mammals: determinants beyond seed pairing", Molecular Cell, vol. 27, no. 1, pp. 91-105, 2007.
79. L. Ma, J. Young, H. Prabhala et al., "MiR-9, a MYC/MYCNactivated microRNA, regulates E-cadherin and cancer metastasis", Nature Cell Biology, vol. 12, no. 3, pp. 247-256, 2010.
80. B. Bonev, P. Stanley, and N. Papalopulu, "MicroRNA-9 modulates hes1 ultradian oscillations by forming a double-negative feedback loop", Cell Reports, vol. 2, no. 1, pp. 10-18, 2012.
81. S. T. Mees, W. A. Mardin, C. Wendel et al., "EP300-a miRNAregulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas", International Journal of Cancer, vol. 126, no. 1, pp. 114-124, 2010.
82. Z. G. Cai, S. M. Zhang, H. Zhang, Y. Y. Zhou, H. B. Wu, and X. P. Xu, "Aberrant expression of microRNAs involved in epithelial-mesenchymal transition of HT-29 cell line", Cell Biology International, vol. 37, no. 7, pp. 669-674, 2013.
83. F. Oswald, M. Winkler, Y. Cao et al., "RBP-Jβ/SHARP recruits CtIP/CtBP corepressors to silence notch target genes", Molecular and Cellular Biology, vol. 25, no. 23, pp. 10379-10390, 2005.
84. S. A. Frank, Dynamics of Cancer: Incidence, Inheritance, and Evolution, Princeton University Press, Princeton, NJ, USA, 2007.
85. B. Zhou, Y. Liu, M. Kahn et al., "Interactions between β-catenin and transforming growth factor-β signaling pathways mediate epithelial-mesenchymal transition and are dependent on the transcriptional co-activator cAMP-response element-binding protein (CREB)-binding protein (CBP)", Journal of Biological Chemistry, vol. 287, no. 10, pp. 7026-7038, 2012.
86. G. Van Der Pluijm, "Epithelial plasticity, cancer stem cells and bone metastasis formation", Bone, vol. 48, no. 1, pp. 37-43, 2011.
87. M. Korpal, E. S. Lee, G. Hu, and Y. Kang, "The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2", Journal of Biological Chemistry, vol. 283, no. 22, pp. 14910-14914, 2008.
88. M. Puhr, J. Hoefer, G. Schäfer et al., "Epithelial-to-mesenchymal transition leads to docetaxel resistance in prostate cancer and is mediated by reduced expression of miR-200c and miR-205", The American Journal of Pathology, vol. 181, no. 6, pp. 2188-2201, 2012.
89. Y. Mizuguchi, S. Specht, J. G. Lunz et al., "Cooperation of p300 and PCAF in the control of microRNA 200c/141 transcription and epithelial characteristics", PLoS ONE, vol. 7, no. 2, Article ID e32449, 2012.